The SORL1 p.Y1816C variant causes impaired endosomal dimerization and autosomal dominant Alzheimer's disease
暂无分享,去创建一个
K. Sleegers | C. van Broeckhoven | M. Hulsman | H. Holstege | L. Benussi | R. Ghidoni | S. J. van der Lee | P. Fojtík | J. Raška | A. Lleó | M. Lunding | V. Pospisilova | J. Van Dongen | G. Monti | A. M. Jensen | O. Dols | D. Bohačiaková | O. Andersen | L. Bossaerts | S. Vochyanova
[1] J. Haines,et al. Polygenic risk score penetrance & recurrence risk in familial Alzheimer disease , 2023, Annals of clinical and translational neurology.
[2] M. Hulsman,et al. Relying on the relationship with known disease-causing variants in homologous proteins to predict pathogenicity of SORL1 variants in Alzheimer’s disease , 2023, bioRxiv.
[3] G. Petsko,et al. Dimerization of the Alzheimer’s disease pathogenic receptor SORLA regulates its association with retromer , 2023, Proceedings of the National Academy of Sciences of the United States of America.
[4] Nick C Fox,et al. Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer’s disease , 2022, Nature Genetics.
[5] Jessica E. Young,et al. Pharmacologic Stabilization of Retromer Rescues Endosomal Pathology Induced by Defects in the Alzheimer’s gene SORL1 , 2022, bioRxiv.
[6] D. Campion,et al. Penetrance estimation of Alzheimer disease in SORL1 loss-of-function variant carriers using a family-based strategy and stratification by APOE genotypes , 2022, Genome medicine.
[7] Nick C Fox,et al. New insights into the genetic etiology of Alzheimer’s disease and related dementias , 2022, Nature Genetics.
[8] Xi Zhang,et al. Cryo-EM structures reveal distinct apo conformations of sortilin-related receptor SORLA. , 2022, Biochemical and biophysical research communications.
[9] S. A. Hussaini,et al. Alzheimer’s vulnerable brain region relies on a distinct retromer core dedicated to endosomal recycling , 2021, Cell reports.
[10] C. van Broeckhoven,et al. Investigating the Endo-Lysosomal System in Major Neurocognitive Disorders Due to Alzheimer’s Disease, Frontotemporal Lobar Degeneration and Lewy Body Disease: Evidence for SORL1 as a Cross-Disease Gene , 2021, International Journal of Molecular Sciences.
[11] D. Hailey,et al. The Alzheimer’s gene SORL1 is a regulator of endosomal traffic and recycling in human neurons , 2021, Cellular and Molecular Life Sciences.
[12] P. Scheltens,et al. SORL1 deficiency in human excitatory neurons causes APP-dependent defects in the endolysosome-autophagy network , 2021, Cell reports.
[13] S. Small,et al. Endosomal trafficking is required for glycosylation and normal maturation of the Alzheimer’s-associated protein sorLA , 2020, bioRxiv.
[14] I. Paatero,et al. A feed-forward loop between SorLA and HER3 determines heregulin response and neratinib resistance , 2020, bioRxiv.
[15] S. Small,et al. Depletion of the AD risk gene SORL1 selectively impairs neuronal endosomal traffic independent of amyloidogenic APP processing , 2020, bioRxiv.
[16] Jakub Pospíšil,et al. Differentiation of neural rosettes from human pluripotent stem cells in vitro is sequentially regulated on a molecular level and accomplished by the mechanism reminiscent of secondary neurulation. , 2019, Stem cell research.
[17] Michael S. Fernandopulle,et al. Transcription Factor–Mediated Differentiation of Human iPSCs into Neurons , 2018, Current protocols in cell biology.
[18] Albert Hofman,et al. The effect of APOE and other common genetic variants on the onset of Alzheimer's disease and dementia: a community-based cohort study , 2018, The Lancet Neurology.
[19] A. Heck,et al. Low pH-induced conformational change and dimerization of sortilin triggers endocytosed ligand release , 2017, Nature Communications.
[20] W. M. van der Flier,et al. Characterization of pathogenic SORL1 genetic variants for association with Alzheimer’s disease: a clinical interpretation strategy , 2017, European Journal of Human Genetics.
[21] Lilah M. Besser,et al. Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score , 2017, PLoS medicine.
[22] W. M. van der Flier,et al. Rare Genetic Variant in SORL1 May Increase Penetrance of Alzheimer’s Disease in a Family with Several Generations of APOE-ɛ4 Homozygosity , 2016, Journal of Alzheimer's disease : JAD.
[23] T. Willnow,et al. Risk factor SORL1: from genetic association to functional validation in Alzheimer’s disease , 2016, Acta Neuropathologica.
[24] Xiaorong Liu,et al. Angiopoietin receptor TEK mutations underlie primary congenital glaucoma with variable expressivity. , 2016, The Journal of clinical investigation.
[25] Giuliano Binetti,et al. A comprehensive study of the genetic impact of rare variants in SORL1 in European early-onset Alzheimer’s disease , 2016, Acta Neuropathologica.
[26] G. Larson,et al. SorLA Complement-type Repeat Domains Protect the Amyloid Precursor Protein against Processing* , 2014, The Journal of Biological Chemistry.
[27] Kevin W Eliceiri,et al. NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.
[28] B. Hyman,et al. Interaction of the Cytosolic Domains of sorLA/LR11 with the Amyloid Precursor Protein (APP) and β-Secretase β-Site APP-Cleaving Enzyme , 2006, The Journal of Neuroscience.
[29] C. van Broeckhoven,et al. novoSNP, a novel computational tool for sequence variation discovery. , 2005, Genome research.
[30] P. Madsen,et al. Activation and Functional Characterization of the Mosaic Receptor SorLA/LR11* , 2001, The Journal of Biological Chemistry.
[31] C Chothia,et al. Conservation of folding and stability within a protein family: the tyrosine corner as an evolutionary cul-de-sac. , 2000, Journal of molecular biology.
[32] S. Blacklow,et al. Protein folding and calcium binding defects arising from familial hypercholesterolemia mutations of the LDL receptor , 1996, Nature Structural Biology.
[33] D C Richardson,et al. The tyrosine corner: a feature of most Greek key beta-barrel proteins. , 1994, Protein science : a publication of the Protein Society.